447 related articles for article (PubMed ID: 28540751)
41. [Current concepts on the physiopathology of adult-onset Still's disease].
Arlet JB; Le Thi Huong DB; Pouchot J; Piette JC
Rev Med Interne; 2005 Jul; 26(7):549-56. PubMed ID: 15996569
[TBL] [Abstract][Full Text] [Related]
42. Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.
Chi H; Liu D; Sun Y; Hu Q; Liu H; Cheng X; Ye J; Shi H; Yin Y; Liu M; Wu X; Zhou Z; Teng J; Yang C; Su Y
Arthritis Res Ther; 2018 Mar; 20(1):54. PubMed ID: 29566725
[TBL] [Abstract][Full Text] [Related]
43. Adult onset Still's disease-The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review).
Junge G; Mason J; Feist E
Semin Arthritis Rheum; 2017 Oct; 47(2):295-302. PubMed ID: 28757235
[TBL] [Abstract][Full Text] [Related]
44. Pathogenesis and management of adult-onset Still's disease.
Efthimiou P; Georgy S
Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
[TBL] [Abstract][Full Text] [Related]
45. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
J Rheumatol; 2004 Nov; 31(11):2189-98. PubMed ID: 15517632
[TBL] [Abstract][Full Text] [Related]
46. Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts.
Leavis HL; van Daele PLA; Mulders-Manders C; Michels R; Rutgers A; Legger E; Bijl M; Hak EA; Lam-Tse WK; Bonte-Mineur F; Fretter P; Simon A; van Paassen P; van der Goes MC; Flendrie M; Vercoutere W; van Lieshout AWT; Leek A; Vastert SJ; Tas SW
Rheumatology (Oxford); 2024 May; 63(6):1656-1663. PubMed ID: 37669122
[TBL] [Abstract][Full Text] [Related]
47. Canakinumab for the treatment of adult-onset Still's disease.
Sfriso P; Bindoli S; Doria A; Feist E; Galozzi P
Expert Rev Clin Immunol; 2020 Feb; 16(2):129-138. PubMed ID: 31957508
[No Abstract] [Full Text] [Related]
48. [Adult onset Still's disease].
Ribi C
Rev Med Suisse; 2008 Apr; 4(154):1039-44. PubMed ID: 18557533
[TBL] [Abstract][Full Text] [Related]
49. "Adolescent-onset Still's disease": characteristics and outcome in comparison with adult-onset Still's disease.
Luthi F; Zufferey P; Hofer MF; So AK
Clin Exp Rheumatol; 2002; 20(3):427-30. PubMed ID: 12102485
[TBL] [Abstract][Full Text] [Related]
50. Adult-onset Still's disease: a review.
Owlia MB; Mehrpoor G
Indian J Med Sci; 2009 May; 63(5):207-21. PubMed ID: 19584494
[TBL] [Abstract][Full Text] [Related]
51. Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series.
Bindoli S; Galozzi P; Doria A; Sfriso P
Joint Bone Spine; 2023 Mar; 90(2):105524. PubMed ID: 36623798
[TBL] [Abstract][Full Text] [Related]
52. [Pathophysiology, subtypes, and treatments of adult-onset Still's disease: An update].
Gerfaud-Valentin M; Sève P; Hot A; Broussolle C; Jamilloux Y
Rev Med Interne; 2015 May; 36(5):319-27. PubMed ID: 25466605
[TBL] [Abstract][Full Text] [Related]
53. Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers.
Ruscitti P; Cipriani P; Masedu F; Iacono D; Ciccia F; Liakouli V; Guggino G; Carubbi F; Berardicurti O; Di Benedetto P; Valenti M; Triolo G; Valentini G; Giacomelli R
BMC Med; 2016 Dec; 14(1):194. PubMed ID: 27903264
[TBL] [Abstract][Full Text] [Related]
54. An Update on the Pathogenic Role of Macrophages in Adult-Onset Still's Disease and Its Implication in Clinical Manifestations and Novel Therapeutics.
Chen PK; Chen DY
J Immunol Res; 2021; 2021():8998358. PubMed ID: 34239943
[TBL] [Abstract][Full Text] [Related]
55. JAK inhibitors in difficult-to-treat adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.
Gillard L; Pouchot J; Cohen-Aubart F; Koné-Paut I; Mouterde G; Michaud M; Reumaux H; Savey L; Belot A; Fautrel B; Mitrovic S
Rheumatology (Oxford); 2023 Apr; 62(4):1594-1604. PubMed ID: 35920788
[TBL] [Abstract][Full Text] [Related]
56. Cardiac tamponade: an unusual feature of adult onset Still's disease.
Moder KG; Miller TD; Allen GL
J Rheumatol; 1995 Jan; 22(1):180-2. PubMed ID: 7699669
[TBL] [Abstract][Full Text] [Related]
57. Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: a case report.
Guignard S; Dien G; Dougados M
Clin Exp Rheumatol; 2007; 25(5):758-9. PubMed ID: 18078628
[TBL] [Abstract][Full Text] [Related]
58. Anakinra in children and adults with Still's disease.
Vastert SJ; Jamilloux Y; Quartier P; Ohlman S; Osterling Koskinen L; Kullenberg T; Franck-Larsson K; Fautrel B; de Benedetti F
Rheumatology (Oxford); 2019 Nov; 58(Suppl 6):vi9-vi22. PubMed ID: 31769856
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-18: a biomarker with therapeutic potential in adult-onset Still's disease.
Chen PK; Wey SJ; Chen DY
Expert Rev Clin Immunol; 2022 Aug; 18(8):823-833. PubMed ID: 35771972
[TBL] [Abstract][Full Text] [Related]
60. Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature.
Thonhofer R; Hiller M; Just H; Trummer M; Siegel C; Dejaco C
Rheumatol Int; 2011 Dec; 31(12):1653-6. PubMed ID: 21240503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
